The Advisory Committee on Immunization Practices has updated its vaccination recommendations for immunocompetent adults aged 65 years or older to extend the interval between receipt of the Prevnar 13 and Pneumovax 23...
PPSV23 pneumococcal vaccination recommendations have undergone several changes A new commentary published in JAMA reinforces the changes by the Centers for Disease and Control (CDC)’s vaccine committee in 2019 regarding...